Alpha 2.0
Login Register
» Articles » PMID: 33647279

Molecular-based Helicobacter Pylori Susceptibility Testing Is Almost Ready for Prime Time

Overview
Journal Gastroenterology
Specialty Gastroenterology
Date 2021 Mar 1
PMID 33647279
Citations 6
Authors
David Y Graham
Affiliations
Soon will be listed here.
Citing Articles

Analysis of the status and risk factors for Helicobacter pylori infection and drug resistance in the Lianyungang area, China.

Yang C, Zhang H, Li S, Zhang Z BMC Gastroenterol. 2025; 25(1):96.

PMID: 39979852 PMC: 11843961. DOI: 10.1186/s12876-025-03692-7.

Controversies regarding management of Helicobacter pylori infections.

Price A, Graham D, Tan M Curr Opin Gastroenterol. 2023; 39(6):482-489.

PMID: 37678189 PMC: 10592071. DOI: 10.1097/MOG.0000000000000981.

Empirical tailored therapy based on genotypic resistance detection for eradication: a systematic review and meta-analysis.

Li M, Wang X, Meng W, Dai Y, Wang W Therap Adv Gastroenterol. 2023; 16:17562848231196357.

PMID: 37667805 PMC: 10475236. DOI: 10.1177/17562848231196357.

Implications of the paradigm shift in management of infections.

Graham D Therap Adv Gastroenterol. 2023; 16:17562848231160858.

PMID: 36950252 PMC: 10026128. DOI: 10.1177/17562848231160858.

Tailored therapy for eradication: A systematic review and meta-analysis.

Ma Q, Li H, Liao J, Cai Z, Zhang B Front Pharmacol. 2022; 13:908202.

PMID: 36160444 PMC: 9495299. DOI: 10.3389/fphar.2022.908202.